Wall Street JournalPfizer Fined $107 Million for Epilepsy Drug Price HikeWall Street JournalLONDON— Pfizer Inc. has been fined £84.2 million ($106.7 million) by the U.K.'s competition regulator for charging the country's National Health Service excessively high prices for an anti-epilepsy drug. The Competition and Markets Authority said ...Pfizer fined record £84.2m for overcharging NHSBBC NewsPfizer has been fined a record £84 million for massively overcharging the NHS for an epilepsy drugBusiness InsiderPfizer, Flynn Fined Record $113 Million Over Epilepsy DrugBloombergDaily Mail -ABC News -The Guardian -Sky Newsall 31 news articles »